Cargando…

EStradiol and PRogesterone in In vitro ferTilization (ESPRIT): a multicenter study evaluating third- versus second-generation estradiol and progesterone immunoassays

PURPOSE: To assess estradiol (E(2)) and progesterone levels during ovarian stimulation determined by third-generation (Gen III) and second-generation (Gen II) Elecsys(®) immunoassays. METHODS: E(2) and progesterone concentrations were measured using Elecsys(®) Gen III and Gen II immunoassays, and pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Polyzos, N. P., Anckaert, E., Drakopoulos, P., Tournaye, H., Schiettecatte, J., Donner, H., Bobba, G., Miles, G., Verhagen-Kamerbeek, W. D. J., Bosch, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431432/
https://www.ncbi.nlm.nih.gov/pubmed/32170594
http://dx.doi.org/10.1007/s40618-020-01211-x
_version_ 1783571578598981632
author Polyzos, N. P.
Anckaert, E.
Drakopoulos, P.
Tournaye, H.
Schiettecatte, J.
Donner, H.
Bobba, G.
Miles, G.
Verhagen-Kamerbeek, W. D. J.
Bosch, E.
author_facet Polyzos, N. P.
Anckaert, E.
Drakopoulos, P.
Tournaye, H.
Schiettecatte, J.
Donner, H.
Bobba, G.
Miles, G.
Verhagen-Kamerbeek, W. D. J.
Bosch, E.
author_sort Polyzos, N. P.
collection PubMed
description PURPOSE: To assess estradiol (E(2)) and progesterone levels during ovarian stimulation determined by third-generation (Gen III) and second-generation (Gen II) Elecsys(®) immunoassays. METHODS: E(2) and progesterone concentrations were measured using Elecsys(®) Gen III and Gen II immunoassays, and progesterone concentrations on the day of ovulation triggering were determined by LC–MS/MS. This was a retrospective, non-interventional study conducted at European tertiary referral infertility clinics in women aged 18–45 years, with a body mass index 18–35 kg/m(2), regular menses, and both ovaries. RESULTS: Serum samples were obtained from 230 women classified by oocyte retrieval as poor (33.0%; 0–3 oocytes), normal (40.9%; 4–15 oocytes), or high (26.1%; > 15 oocytes) responders. E(2) and progesterone levels increased during ovarian stimulation, with greatest increases observed in high responders. Elecsys(®) Gen III and Gen II assay results were highly correlated for E(2) (Pearson’s r = 0.99) and progesterone (r = 0.89); Gen III results were lower than Gen II for both E(2) and progesterone. On the day of triggering, Gen III E(2) and progesterone levels showed a difference of − 15.0% and − 27.9%, respectively. Progesterone levels (on day of triggering) measured by LC–MS/MS correlated better with Gen III (0.98) than Gen II (0.90). Mean relative differences for Gen III and Gen II assays versus LC–MS/MS were 14.6% and 62.8%, respectively. CONCLUSION: E(2) and progesterone levels determined with Elecsys(®) Gen II and III assays were highly correlated; results were lower for Gen III versus Gen II. Differences observed for progesterone on the day of triggering may be clinically relevant. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s40618-020-01211-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7431432
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-74314322020-08-24 EStradiol and PRogesterone in In vitro ferTilization (ESPRIT): a multicenter study evaluating third- versus second-generation estradiol and progesterone immunoassays Polyzos, N. P. Anckaert, E. Drakopoulos, P. Tournaye, H. Schiettecatte, J. Donner, H. Bobba, G. Miles, G. Verhagen-Kamerbeek, W. D. J. Bosch, E. J Endocrinol Invest Original Article PURPOSE: To assess estradiol (E(2)) and progesterone levels during ovarian stimulation determined by third-generation (Gen III) and second-generation (Gen II) Elecsys(®) immunoassays. METHODS: E(2) and progesterone concentrations were measured using Elecsys(®) Gen III and Gen II immunoassays, and progesterone concentrations on the day of ovulation triggering were determined by LC–MS/MS. This was a retrospective, non-interventional study conducted at European tertiary referral infertility clinics in women aged 18–45 years, with a body mass index 18–35 kg/m(2), regular menses, and both ovaries. RESULTS: Serum samples were obtained from 230 women classified by oocyte retrieval as poor (33.0%; 0–3 oocytes), normal (40.9%; 4–15 oocytes), or high (26.1%; > 15 oocytes) responders. E(2) and progesterone levels increased during ovarian stimulation, with greatest increases observed in high responders. Elecsys(®) Gen III and Gen II assay results were highly correlated for E(2) (Pearson’s r = 0.99) and progesterone (r = 0.89); Gen III results were lower than Gen II for both E(2) and progesterone. On the day of triggering, Gen III E(2) and progesterone levels showed a difference of − 15.0% and − 27.9%, respectively. Progesterone levels (on day of triggering) measured by LC–MS/MS correlated better with Gen III (0.98) than Gen II (0.90). Mean relative differences for Gen III and Gen II assays versus LC–MS/MS were 14.6% and 62.8%, respectively. CONCLUSION: E(2) and progesterone levels determined with Elecsys(®) Gen II and III assays were highly correlated; results were lower for Gen III versus Gen II. Differences observed for progesterone on the day of triggering may be clinically relevant. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s40618-020-01211-x) contains supplementary material, which is available to authorized users. Springer International Publishing 2020-03-13 2020 /pmc/articles/PMC7431432/ /pubmed/32170594 http://dx.doi.org/10.1007/s40618-020-01211-x Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Article
Polyzos, N. P.
Anckaert, E.
Drakopoulos, P.
Tournaye, H.
Schiettecatte, J.
Donner, H.
Bobba, G.
Miles, G.
Verhagen-Kamerbeek, W. D. J.
Bosch, E.
EStradiol and PRogesterone in In vitro ferTilization (ESPRIT): a multicenter study evaluating third- versus second-generation estradiol and progesterone immunoassays
title EStradiol and PRogesterone in In vitro ferTilization (ESPRIT): a multicenter study evaluating third- versus second-generation estradiol and progesterone immunoassays
title_full EStradiol and PRogesterone in In vitro ferTilization (ESPRIT): a multicenter study evaluating third- versus second-generation estradiol and progesterone immunoassays
title_fullStr EStradiol and PRogesterone in In vitro ferTilization (ESPRIT): a multicenter study evaluating third- versus second-generation estradiol and progesterone immunoassays
title_full_unstemmed EStradiol and PRogesterone in In vitro ferTilization (ESPRIT): a multicenter study evaluating third- versus second-generation estradiol and progesterone immunoassays
title_short EStradiol and PRogesterone in In vitro ferTilization (ESPRIT): a multicenter study evaluating third- versus second-generation estradiol and progesterone immunoassays
title_sort estradiol and progesterone in in vitro fertilization (esprit): a multicenter study evaluating third- versus second-generation estradiol and progesterone immunoassays
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431432/
https://www.ncbi.nlm.nih.gov/pubmed/32170594
http://dx.doi.org/10.1007/s40618-020-01211-x
work_keys_str_mv AT polyzosnp estradiolandprogesteroneininvitrofertilizationespritamulticenterstudyevaluatingthirdversussecondgenerationestradiolandprogesteroneimmunoassays
AT anckaerte estradiolandprogesteroneininvitrofertilizationespritamulticenterstudyevaluatingthirdversussecondgenerationestradiolandprogesteroneimmunoassays
AT drakopoulosp estradiolandprogesteroneininvitrofertilizationespritamulticenterstudyevaluatingthirdversussecondgenerationestradiolandprogesteroneimmunoassays
AT tournayeh estradiolandprogesteroneininvitrofertilizationespritamulticenterstudyevaluatingthirdversussecondgenerationestradiolandprogesteroneimmunoassays
AT schiettecattej estradiolandprogesteroneininvitrofertilizationespritamulticenterstudyevaluatingthirdversussecondgenerationestradiolandprogesteroneimmunoassays
AT donnerh estradiolandprogesteroneininvitrofertilizationespritamulticenterstudyevaluatingthirdversussecondgenerationestradiolandprogesteroneimmunoassays
AT bobbag estradiolandprogesteroneininvitrofertilizationespritamulticenterstudyevaluatingthirdversussecondgenerationestradiolandprogesteroneimmunoassays
AT milesg estradiolandprogesteroneininvitrofertilizationespritamulticenterstudyevaluatingthirdversussecondgenerationestradiolandprogesteroneimmunoassays
AT verhagenkamerbeekwdj estradiolandprogesteroneininvitrofertilizationespritamulticenterstudyevaluatingthirdversussecondgenerationestradiolandprogesteroneimmunoassays
AT bosche estradiolandprogesteroneininvitrofertilizationespritamulticenterstudyevaluatingthirdversussecondgenerationestradiolandprogesteroneimmunoassays